NEURAXON(USA), INC.

Profile

Company Names

NEURAXON(USA), INC.

Addresses

2395 SPEAKMAN DRIVE, SUITE 1001, MISSISSAUGA, A6 L5K 1B3

480 UNIVERSITY AVENUE, SUITE 900, TORONTO, A6 M5G 1V2

Phone Numbers

416-673-6697

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$4,350,388.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2012-03-23 
$782,171.00 
$2,959,565.00 
$2,177,394.00 
Debt 
1
2009-12-21 
$3,568,217.00 
$3,568,217.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JOHN 
S. 
ANDREWS 
EXECUTIVE OFFICER, DIRECTOR
NEURAXON(USA), INC.
LAWRENCE 
E. 
BLOCH 
EXECUTIVE OFFICER, DIRECTOR
NEURAXON(USA), INC.
AARON 
 
DAVIDSON 
DIRECTOR
HYPERBRANCH MEDICAL TECHNOLOGY INC   |  GEMIN X PHARMACEUTICALS INC   |  QUINNOVA PHARMACEUTICALS, INC.   |  NEURAXON(USA), INC.   |  TRANZYME INC   |  INTACT VASCULAR, INC.   |  CARDEAS PHARMA CORP   |  FORSIGHT VISION5, INC.   |  CONAVI MEDICAL CORP.   |  PERIMETER MEDICAL IMAGING AI, INC.
KENNETH 
 
GALBRAITH 
DIRECTOR
ZYMEWORKS INC.   |  PRESIDIO PHARMACEUTICALS, INC.   |  NEURAXON(USA), INC.   |  CELATOR PHARMACEUTICALS INC   |  AQUINOX PHARMACEUTICALS (USA) INC   |  AQUINOX PHARMACEUTICALS INC   |  PROFOUND MEDICAL CORP.   |  PROMETIC LIFE SCIENCES INC   |  ZYMEWORKS INC.
JONATHAN 
R. 
GOODMAN 
DIRECTOR
NEURAXON(USA), INC.
TOM 
 
LATEGAN 
EXECUTIVE OFFICER
NEURAXON(USA), INC.
SHAWN 
 
MADDAFORD 
EXECUTIVE OFFICER
NEURAXON(USA), INC.
ROBERT 
A. 
MEDVE 
EXECUTIVE OFFICER
NEURAXON(USA), INC.
DEEPA 
 
PAKIANATHAN 
DIRECTOR
PTC THERAPEUTICS, INC.   |  NEURAXON(USA), INC.   |  RELYPSA INC   |  CALITHERA BIOSCIENCES, INC.   |  ONCOMED PHARMACEUTICALS INC
SUMAN 
 
RAKHIT 
EXECUTIVE OFFICER
NEURAXON(USA), INC.
ANDREW 
 
SANDHAM 
DIRECTOR
NEURAXON(USA), INC.
SAMUEL 
P. 
WERTHEIMER 
DIRECTOR
NEURAXON(USA), INC.   |  CERIMON PHARMACEUTICALS, INC.   |  POLIWOGG HOLDINGS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2012-05-01
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-03-23 
2010-03-16
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-12-21 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#